Press Releases
Histogenics Corporation to Present at Canaccord Genuity Musculoskeletal Conference
Histogenics Corporation, a privately held, regenerative medicine company, today announced that President and Chief Executive Officer Patrick O’Donnell will present at the upcoming Canaccord Genuity Musculoskeletal Conference on February 7th at 3:30pm PT at the Parc 55 Wyndham in...
Press Releases
Alize Pharma licenses its ASPAREC(R) therapy for treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma
Alize Pharma II, a drug development company focused on oncology and metabolism and part of the Alize Pharma group, announced today the signing of a licensing agreement with EUSA Pharma for ASPAREC(R), a new L-asparaginase product currently in...
Press Releases
PerkinElmer Elects Peter Barrett to Board of Directors
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that Peter Barrett, a partner at Atlas Venture, an early stage technologies and life sciences venture capital fund, has...
Press Releases
Unilens Vision Inc. Declares Quarterly Cash Dividend of $0.045 Per Share
The Unilens Vision Inc.Board of Directors today declared a quarterly cash dividend of $0.045 per common share, payable February 24,2012 to stockholders of record at the close of business on February 10, 2012. About...
Press Releases
Hi-Tech Pharmacal Receives Final Approval for Lorazepam Oral Concentrate
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, granted final approval for the Company's Abbreviated New Drug Application, for Lorazepam oral concentrate 2mg/mL, the generic for Roxanne’s Lorazepam Intensol®...
Press Releases
PharMerica Comments on FTC Decision to Block Omnicare’s Hostile Tender Offer
PharMerica Corporation , a national provider of institutional pharmacy and hospital pharmacy management services, today commented on the decision by the Federal Trade Commission to sue to block Omnicare’s unsolicited offer to acquire PharMerica. ...
Press Releases
Spectrum Pharmaceuticals Strengthens Commercial Operations
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the promotions of Rick Gonzalez to Senior Vice President, Commercial; Andrew W. Amstrup...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read